Gilead Sciences has promoted Jim Meyers to SVP, commercial operations, North America. Meyers is responsible for the company's commercial organization in North America, including U.S. and Canadian sales, marketing and commercial operations, reporting to Kevin Young, Gilead's EVP, Commercial Operations. Meyers joined Gilead in 1996 as a regional sales director and relocated to the company's headquarters in 1997 to head the HIV marketing team. In 2001, he was named senior director of US sales, overseeing the expansion of the company's field sales organization in advance of the launch of Gilead's first product for the treatment of HIV. He was promoted to VP in 2002, and appointed to the position of VP of the US commercial organization in 2004. Prior to joining Gilead, Meyers held positions of increasing responsibility in sales, training, marketing and management with Zeneca Pharmaceuticals and Astra USA.
Eisai has announced the following new hires and promotions. Jianbin Xue has been hired as senior manager, business analytics. Joseph DaBronzo, has been hired as director, scientific & professional education. John Purvis has been hired as manager, internal audit. Hanife Akin has been hired as principle scientist. Blair Tyson has been hired as senior manager, aseptic operations. Mabel Lam Tse has been promoted from drug information manager to senior drug information manager. Geoffrey Hird has been promoted from research scientist I to research scientist II. Antonia LoPresti-Solis has been promoted from medical director to senior medical director, medical services. Nicole Merlo has been promoted from associate product manager to product manager. Jason Prabel has been promoted from research scientist I to research scientist II. Kim Van Iderstine has been promoted from associate product manager to product manager. Sara Wu has been promoted from research scientist I to research scientist II. Bing Yuan has been promoted from marketing manager, new products to senior manager, global medical & marketing services. Anita Garrett has been promoted from microbiologist III to microbiologist IV.
Bernard Poussot has been elected to the position of president, COO and vice chairman at Wyeth. In addition, Poussot was elected to the company's board of directors increasing the number of Wyeth’s board members to 13.
InVentiv Health unit GSW Worldwide named Thomas Doyle copy supervisor in its New York office. Most recently, Doyle served as copy supervisor for Grey Healthcare Group where he developed ad campaigns and created marketing materials. Doyle previously spent two years as market research writer and analyst for StarrTrack Market Research, where he was responsible for creating marketing materials for the vitamins, supplements and minerals industry. He began his career as entertainment editor for The Arcata Eye newspaper. Doyle was responsible for writing stories as well as conceiving and implementing business and editorial strategies.
DraftFCB HealthCare has hired Harold Corbran, Jr. as EVP/COO, the same title he has held since 2003 with former employer Euro RSCG Life. Corbran will be responsible for running general operations and identifying growth opportunities. He brings 30 years’ experience in healthcare, including stints with Euro’s Marketing Services Group, Pfizer legacy company Parke-Davis and medical education firms Healthscan and SCIENS Worldwide.
John Haig has been named VP, marketing research of The Mattson Jack Group. Prior, Haig was associate professor of psychology at Philadelphia University.
IMS Health announced that Gilles Pajot, EVP and president, global business management, has been named the company's COO. IMS also appointed Leslye Katz, IMS VP and controller, as SVP and CFO.